methyl methanesulfonate has been researched along with Cancer of Gastrointestinal Tract in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheikh, MS | 1 |
| Huang, Y | 1 |
| Fernandez-Salas, EA | 1 |
| El-Deiry, WS | 1 |
| Friess, H | 1 |
| Amundson, S | 1 |
| Yin, J | 1 |
| Meltzer, SJ | 1 |
| Holbrook, NJ | 1 |
| Fornace, AJ | 1 |
1 other study available for methyl methanesulfonate and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma; | 1999 |